Clinical Trial Detail

NCT ID NCT02298153
Title A Study of MPDL3280A in Combination With INCB024360 in Subjects With Previously Treated Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Epacadostat

Age Groups: adult

No variant requirements are available.